Clinical trial Recruiting at 2 sites Interventional Ages 18 and up Women only

Improving postpartum care access through telemedicine

Official title: IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine

Run by University of Texas Southwestern Medical Center · NCT06218355 · Data updated 2026-11-12

This study is testing two different ways to provide postpartum care—one with in-person education and virtual support, and the other through telehealth—to see which helps new mothers from underserved communities stay healthier after childbirth.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment3500 (estimated)
SponsorUniversity of Texas Southwestern Medical Center
Academic / other
Locations2 sites (Atlanta, Georgia and 1 other locations)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedSeptember 1, 2027
Study endsSeptember 1, 2028
Registry record updatedSeptember 2, 2026
Trial IDNCT06218355 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are postpartum women aged 18 and older who deliver liveborn infants at Parkland Hospital or Grady Health and receive care at designated community clinics.

Probably not a fit

Patients who deliver outside of the specified hospitals or who primarily speak a language other than English or Spanish may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare two evidence-based postpartum care models to reduce maternal morbidity and mortality among underserved populations. It will involve a large, multi-center randomized controlled trial with two phases: the first phase will gather baseline data and patient input, while the second phase will randomize participants to either an intensive in-person education model with virtual support or a telehealth model with serial encounters. Both models will include home visit programs and will focus on addressing postpartum complications such as hypertension and wound infections. The study will follow women for one year postpartum to assess various health outcomes.

Why it matters

Potential benefit: If successful, this study could significantly improve access to postpartum care and reduce complications for mothers in underserved communities.

How similar studies have gone: Other studies have shown success with similar telemedicine approaches in improving maternal health outcomes, suggesting a promising avenue for this intervention.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Postpartum women who deliver a live born infant at Parkland Hospital or Grady Health and receive postpartum care at dedicated community clinics.
* Due to the nature of the study, all will be women, and all will be postpartum, thus of reproductive age. Postpartum women 18 years of age and older will be considered for inclusion if informed consent can be obtained.

Exclusion Criteria:

* Postpartum women who do not deliver at Parkland Hospital or Grady Health will not receive postpartum care in the pre-specified community clinics for Parkland health systems.
* Patients with a primary language other than English or Spanish.

Where it's running

  • Grady Memorial Hospital
    Atlanta, Georgia, United States
    Recruiting
  • Parkland Hospital
    Dallas, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.